How the 2028 Medicare drug price negotiations will reshape market access, provider reimbursement, and patient care ...

Tiara Green, president, Accessia Health, explains how empowering trusted local leaders and involving communities early are ...

The afternoon of day 2 at Asembia’s AXS25 Summit offered various intriguing sessions to pick from, including one on ...

Joydeep Ganguly, SVP, corporate operations, interim CIO, Gilead Sciences, shares how stakeholders can drive meaningful, ...

Doug Long, VP, industry relations, IQVIA, examines shifting pharmaceutical trends, including specialty growth, biosimilar ...

A multi-national study reveals over half of older adults in several European countries are prescribed five or more ...

Will Pih, co-founder, Two Labs, explains how specialty pharmacies and manufacturers are adapting to financial pressures in rare disease care through patient-centric services, hub innovation, and ...

In the final part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Paul Levesque, CEO of ...

In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Paul Levesque, CEO of ...

The deal for the San Diego hub provides the CDMO with its first-ever North American manufacturing location for prefilled ...

A session dives into the trends surrounding specialty drugs and therapies, along with providing an overview of the drug ...

Subject matter experts share the challenges that patients face in terms of medication affordability, along with the role that ...